Blockchain

Dora Factory Announces Historic $DORA Airdrop to Over 1 Million ATOM Stakers in Largest MACI Voting Round Ever

Singapore, SIngapore, June 6th, 2024, Chainwire

 

Dora Factory, the pioneering infrastructure of decentralized governance technology and public good funding, announces the gas fee airdrop of its native token, $DORA, to all ATOM stakers on June 5, 2024. Over one million addresses are eligible to receive $DORA token, with the airdrop campaign inviting the Cosmos community to participate in the governance of its democratic public goods funding program, the ATOM Economic Zone Quadratic Funding, on DoraHacks.io. With 1.04 million addresses whitelisted, the privacy voting round implemented by the Dora team will be the largest MACI (Minimum Anti Collusion Infrastructure) voting round ever.

1.04 million ATOM stakers are eligible for the airdrop

On June 5, all ATOM stakers have received $DORA tokens in their wallets. $DORA is the native token of Dora Vota, a decentralized governance application chain developed by the Dora Factory using the Cosmos SDK.

This airdrop is one of the largest in history. With over one million addresses, Dora Factory aims to mobilize the Cosmos community, known for its passion for decentralized governance, to participate in a crucial public goods governance experiment for the community.

Empowering Community with AEZ Funding and MACI Voting

After receiving the airdrop, Cosmos communities can participate in the ATOM Economic Zone (AEZ) quadratic funding initiative jointly launched by DoraHacks, Dora Factory, and ATOM Accelerator DAO. They can use ATOM to vote for and donate to public goods teams they value, support early-stage developers, and determine the distribution of an 80,000 ATOM and $200,000 USDC matching pool across 10 rounds of AEZ Quadratic Funding and MACI voting. The smart contracts for this quadratic voting round are deployed on the Dora Vota network, and the community can use $DORA to cover gas fees.

This campaign goes beyond merely distributing the reward pool to early-stage projects and essential public goods in AEZ in the first round; it is a democratic governance experiment designed to mobilize community power in supporting public goods and promising early-stage developers. The quadratic funding mechanism ensures that even small donations from community members have a substantial impact.

MACI Voting With Enshrined Privacy

Dora Factory invites community members to participate in MACI (Minimal Anti-Collusion Infrastructure) privacy voting, distributing a $20,000 USDC prize pool to selected teams. Unlike traditional quadratic voting, this method allows voters to express their opinions on public goods without revealing their identity (address). Addresses with more ATOM staked will receive more Voice Credits (voting power).

Through MACI voting, Dora Factory aims to introduce cutting-edge privacy-enabled voting technology to the Cosmos community. This initiative marks the beginning of integrating secure, private, and anti-collusion technologies into a wider range of governance use cases in the future.

Dora Factory’s Dedication

To ensure every community member can participate in MACI voting without concerns, Dora Factory will implement Dora Vota’s native Gas Station feature to cover all voting fees for the MACI voting round. This fee subsidy represents Dora Factory’s commitment to the community outlined in Cosmos Governance Proposal 917.

A Historical Community Governance Ceremony

With the quadratic funding module now natively implemented on Dora Vota for the Cosmos Hub, Cosmos has the potential to become one of the largest on-chain communities that supports public goods. The first round of the two-year quadratic funding plan for the ATOM Economic Zone commencing in June 2024 has attracted numerous outstanding projects and awaits the attention and support of community members.

The Largest Privacy-Preserving Governance Experiment

MACI implementation is a groundbreaking step for the Cosmos community, as its first privacy voting attempt. Dora Factory has whitelisted over 1 million addresses, setting a new record for the largest whitelist, and marking the largest voting experiment in MACI’s history. The Dora Factory team is excited to invite the Cosmos community to create a historic moment collectively.

About Dora Factory

Dora Factory is at the forefront of decentralized governance protocol stacks, providing governance and long-term incentives for the global hacker movement, open-source communities, and decentralized organizations through Public Good Staking and Dora Vota. The platform has pioneered the development of public good staking infrastructure, revolutionizing the way developers are funded long-term in the PoS ecosystem. Additionally, Dora Vota offers a comprehensive decentralized governance platform, enabling users to create programmable governance mechanisms such as MACI and quadratic voting through its open platform. This reduces the cost of decentralized governance, laying a solid foundation for its widespread adoption.

To better understand and try the products of Dora Factory, users can visit DoraFactory.org.

Users can visit Dora Research Blog for more details: research.dorahacks.io

 

Contact

Contributor
Chris Lee
Dora Factory
[email protected]

PostAd_coinrule_banner728x90

Comments are closed.

Equasens: 2024 half-year results

2024-09-27T16:00:00Z

Villers-lès-Nancy, 27 September 2024 - 6:00 p.m. (CET)

PRESS RELEASE

2024 half-year results

  • Group results impacted by weaker economic conditions and continuing investment efforts in H1:
    • Revenue: €108.0m, -4.1%
    • Current Operating Income: €20.9m, -24.1%
  • Net Profit attributable to the Group: €17.2m, -21.8%
  • Though with a profit margin that continues to be very positive:
    • Ratio of Current Operating Income (COI) to Sales: 19.3% on a reported basis and 20.0% like-for-like
H1 RESULTS (€M)2023
reported basis
2024
reported basis
Change / Reported basisExternal growthChange / Like-for-like basis
Revenue112.6108.0-4.6-4.1%-3.7-8.3-7.4%
Current operating income (COI)27.520.9-6.6-24.1%0.0-6.7-24.3%
Net Profit22.918.1-4.8-21.0%0.0-4.8-21.1%
Net Profit attributable to the Group22.017.2-4.8-21.8%   

The financial statements for the six-month period ended 30 June 2024 were reviewed and adopted by EQUASENS' Board of Directors, chaired by Thierry Chapusot, on 27 September 2024. These interim consolidated financial statements were subject to a limited review by the Statutory Auditors.

_____

Results at 30 June 2024

H1 Current Operating Income / Division2023
reported basis
2024
reported basis
Change / Reported basisExternal growthChange / Like-for-like basis
Pharmagest18.414.1-4.3-23.5%-0.1-4.4-24.0%
Axigate Link4.64.4-0.2-4.9% -0.2-4.9%
e-Connect3.62.5-1.1-29.9% -1.1-29.9%
Medical Solutions1.30.0-1.3-100.0%0.1-1.2-92.5%
Fintech-0.4-0.10.369.3% 0.3-69.3%
Current Operating Income27.520.9-6.6-24.1%0.0-6.7-24.3%
  • PHARMAGEST division: a contraction in earnings reflecting lower sales and reinforced teams in Europe (COI/Sales: 17.2%)

The decline in the Division's operating income is mainly attributable to a reduction in sales in France in the configuration and hardware segment. In a persistently challenging economic environment, the Division continued to focus its commercial strategy on acquiring new customers and regularly rolling out new software and hardware solutions.
Despite this, recurring revenues were bolstered by the combined contribution of new SaaS offerings and contract indexation.
To accelerate the deployment of solutions in Europe, the R&D and sales teams continued to be strengthened.

  • AXIGATE LINK division: the profit margin remains high (COI/Sales: 28.6%)

Strategic investments to support the roll-out of SaaS solutions such as TitanLink for Nursing Homes in Europe, and the extension of homecare services, have temporarily weighed on the Division's results.

  • E-CONNECT division: current operating income declined in response to lower sales (COI/Sales: 45.4%)

As previously reported, H1 2023 sales and earnings were boosted by the announced discontinuation of sales of Application Reader Terminals.
The downturn in business in the first half of 2024 thus reflected the corresponding decline in sales.
Despite this unfavourable environment, the Division demonstrated its ability to adapt by maintaining a healthy profit margin based on tight cost controls.

  • MEDICAL SOLUTIONS division: a year of transition between the Ségur digital healthcare investment programme and a new software solution (COI/Sales: -)

Preparations for the Division's future involving the development of a new software platform and optimising the sales organisation led to significant investments which, in conjunction with lower sales following the end of the Ségur programme roll-out, weighed on the Division's results. Recurring revenues rose 13.7%, resulting in a gross margin of 72.8%.

  • FINTECH division: efforts to stabilise the business paid off in H1, with an improvement in earnings of €0.3m (COI/Sales: -)

Consolidated balance sheet highlights

  • Cash flow after interest and tax maintained a positive trend at €20.8m.
  • Financial investments, through acquisitions as well as capital expenditures, in particular for the EQUASENS private healthcare cloud, continued, with more than €16.0m committed in H1.
  • The net financial surplus at 30/06/2024 of €87.9m takes into account a change in presentation of IFRS 16 lease liabilities and put options for minority shareholders of €10.8m (recognised under other liabilities versus financial liabilities previously).

2024 outlook

  • The Group maintains its forecast for a return to revenue growth starting in the second half of 2024, and an acceleration in 2025 driven by current investments and an economic climate that looks set to improve, particularly for pharmacies in France.
  • The Group will continue to invest in R&D, infrastructure and sales forces in France and Europe in the second half of 2024. And while this will have a temporary impact on profitability in 2024, it should generate a return on investment from 2025 onwards.
  • With a strategy focused on patients and interoperability, the Group is ideally positioned to seize opportunities for external growth in France and Europe.

Financial calendar:

  • 1 October 2024: Presentation of H1 2024 results
  • 7 November 2024: Publication of Q3 2024 revenue
  • 6 February 2025: Publication of f Q4/FY 2024 revenue

About Group Equasens

With more than 1,300 employees, Equasens Group is today a key player in the European healthcare sector, providing software and hardware solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, hospital-at-home programmes, retirement homes, health centres) in both primary and secondary care sectors.

With operations in in France, Germany, Great Britain, Belgium, Ireland, Italy, and Luxembourg, Equasens Group today brings together healthcare professionals within a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

Listed on Euronext Paris™ - Compartment B

Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable
Included in the Euronext Tech Leaders segment and the European Rising Tech label

Eligible for the Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
ISIN: FR 0012882389 – Ticker Code: EQS

Get all the news about Equasens Group www.equasens.com and on LinkedIn

CONTACTS

Analyst and Investor Relations:
Chief Administrative and Financial Officer: Frédérique Schmidt
Tel: +33 (0)3 83 15 90 67 - [email protected]

Financial communication agency:
FIN’EXTENSO - Isabelle Aprile

Tel.: +33 (0)6 17 38 61 78 - [email protected]

Attachment


GlobeNewsWire News

Recent Comments